The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Path: Organizing pneumonia (OP/BOOP) pattern (see also Id)
Publications
Non-neoplastic inflammatory pseudotumor of the lung after immunotherapy for melanoma: A diagnostic pitfall on fine needle aspiration biopsy of lung.
Diagnostic cytopathology 2021 Jul 31;; — 2021 Jul 31
Mesalazine-induced Bronchiolitis Obliterans With Organising Pneumonia in a Young Patient With Ulcerative Colitis.
Journal of Crohn's & colitis 2018 Nov 15;12;1377-1378 — 2018 Nov 15 — 1377-1378
Mahjoubi L, Gazzah A, Marabelle A, Le Roy Ladurie F, Lambotte O, Caramella C, Adam J, Besse B, Soria JC
Late-occurring nivolumab-induced cryptogenic organising pneumonia mimicking lung progression in a patient with metastatic non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 2017 11;85;155-157 — 2017 11 — 155-157
Kiyohara Y, Yoshikawa S, Otsuka M, Kondou R, Iizuka A, Nonomura C, Ohshima K, Urakami K, Kusuhara M, Nagashima T, Sugino T, Yamaguchi K, Akiyama Y
Melanoma patient response to nivolumab treatment for metastatic lung lesions: Multi-OMICS analysis in Project HOPE.
The Journal of dermatology 2017 Oct;44;1156-1159 — 2017 Oct — 1156-1159
Nivolumab-induced organizing pneumonia in a melanoma patient.
Japanese journal of clinical oncology 2016 Mar;46;270-2 — 2016 Mar — 270-2
Organizing Pneumonia Induced by Nivolumab in a Patient with Metastatic Melanoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Mar;11;432-3 — 2016 Mar — 432-3